Robert Blazej

Telo Therapeutics, Inc. develops precision medicines to reverse cancer cell immortality.

BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D. Parker and Susie T. Harborth. The firm is headquartered in Cambridge, Massachusetts.

Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California.

MBC Biolabs is a company that provides space and equipment to life-science startups, allowing them to be fast, focused, and frugal. The company has four sites, one in the Mission Bay neighborhood in San Francisco, CA, and two campuses in other locations. MBC Biolabs has partnerships with leading pharmaceutical and life-science companies, as well as a built-in venture capital firm, Mission BioCapital, which provides entrepreneurs with valuable insights about where to focus their efforts and accelerates the innovation pipeline. Since opening in 2013, MBC Biolabs has helped launch and grow over 300 companies, which have brought 153 programs to the clinic, produced 13 approved diagnostics, and raised over $143 billion.

Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.

Allopartis Technologies Inc. develops industrial and therapeutic proteins. The company was founded by Robert Blazej, Charles Emrich and Nicholas Toriello in 2008 and is headquartered in San Francisco, CA.